When Evidence Gap Becomes a Commercial Liability
The MENA evidence gap for selected portfolios is becoming a commercial liability for drugmakers that could have been prevented at the design stage.
The MENA evidence gap for selected portfolios is becoming a commercial liability for drugmakers that could have been prevented at the design stage.
Creativity comes in many forms, and sometimes, even with creating medical innovations, being frugal can be a viable option - At least it has been for Muhammad Mustafa Hussain, an associate professor of electrical engineering at the King Abdullah University of Science and Technology in Thuwal, Saudi Arabia.
Health systems with a high profile have been expanding their brand name through collaborations around the U.S. But given the fact that some of these U.S. hospital brands can attract an international clientele, some have been making moves to expand their brand in emerging markets. Johns Hopkins Medicine’s latest move is a joint venture with […]
RIYADH (Reuters) - Saudi Arabia said another person had died of the SARS-like coronavirus MERS, and six new cases were registered, in statements on Thursday and Friday as international experts gather in Cairo to discuss the epidemic. Experts, including...